Welcome to the e-CCO Library!

P511: Evaluation of home faecal calprotectin testing to aid remote management and enhanced self-management of Inflammatory Bowel Disease.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Allen, K.(1)*;Munuswamy, P.(2);
Created: Friday, 14 July 2023, 11:05 AM
P511: Radiological outcomes in perianal fistulising Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Lee*1, M. Kamm2, S. Bell2, M. Lust2, S. Brown2, E. Wright2, W. Connell2, E. Yong3, N. Ding2

Created: Friday, 22 February 2019, 9:41 AM
P511: Utilisation and efficacy of oral iron therapy in patients with iron deficiency anaemia in a nationwide cohort of ulcerative colitis patients
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

D. Patel*1, N. Khan2

Created: Friday, 22 February 2019, 9:49 AM
P512 Efficacy of tofacitinib for the treatment of moderate-to-severe ulcerative colitis: real-world data
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. XIAO1, P.L. Lakatos2, R. Bourdages3, A. Bitton2, W. Afif2, R. Kohen2, M. Berberi3, T. Bessissow2

Created: Thursday, 30 January 2020, 10:12 AM
P512: Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib
Year: 2018
Source: ECCO '18 Vienna
Authors:

K.L. Winthrop1, G.Y. Melmed2, S. Vermeire3*, M.D. Long4, G. Chan5, R.D. Pedersen5, N. Lawendy5, A.J. Thorpe5, C.I. Nduaka5, C. Su5

Created: Thursday, 21 February 2019, 9:14 AM
P512: Real world use of adalimumab: effects on corticosteroid treatment and hospital resource utilisation in UK patients with moderate/severe ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Watts G.*1, Arasaradnam R.2, Travis S.3, Sharma A.4, Awasthi A.5, Limdi J.6, Bishop-Bailey A.7, Mclain-Smith S.7, Finney-Hayward T.8

Created: Wednesday, 20 February 2019, 10:36 AM
P512: Results of interim analysis of a retrospective IGIBD study on adalimumab use in real practice in Italy: the REAL-life clinical effectiveness of ADAlimumab in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

D. Pugliese1, M. Mendolaro2, R. D'Incà3, D. G. Ribaldone4, M. Principi5, C. Ricci6, E. Stasi7, M. L. Scribano8, G. Bodini9, S. Saibeni10, A. C. Privitera11, D. Simondi12, A. Armuzzi1, M. Daperno*2, Italian Group for Inflammatory Bowel Disease (IGIBD)1

Created: Friday, 22 February 2019, 9:41 AM
P512: Safety of reduced clinical monitoring in patients with stable Inflammatory Bowel Disease on maintenance thiopurine therapy
Year: 2021
Source: ECCO'21 Virtual
Authors: Jansen, F.M.(1);Smits, L.S.(1);Thomas, P.W.A.(1);den Broeder, N.(1);de Jong, D.J.(1);van Dop, W.A.(1);Hoentjen, F.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P512: The counts of white blood cells are not predictive for long-term remission under treatment with thiopurines: a three year Japanese multi-center retrospective cohort study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kiyohara, H.(1,2)*;Yamazaki, H.(3);Moriya, K.(4);Akimoto, N.(5);Kawai, S.(6);Kobayashi, T.(1);
Created: Friday, 14 July 2023, 11:05 AM
P512: Vedolizumab is effective in the prevention and treatment of postoperative recurrence in patients with Crohn´s disease
Year: 2022
Source: ECCO'22
Authors: Kadleckova, B.(1);Podmanicky, D.(2);Lipovska, A.(1);Zelinkova, Z.(1);
Created: Friday, 11 February 2022, 3:56 PM
P513 has been withdrawn
Year: 2020
Source:

ECCO'20 Vienna

Created: Thursday, 30 January 2020, 10:12 AM
P513: Assessment of quality indicators in The Swedish Inflammatory Bowel Disease Registry (SWIBREG) for Crohn’s Disease treated with biological therapies
Year: 2021
Source: ECCO'21 Virtual
Authors: Xu, C.(1);Byman, V.(2);Hossain, J.(2);Storlåhls, A.(2);Hedin, C.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P513: Early initiation of anti-TNF is associated with favourable long-term outcome in Crohn’s disease: Ten-year follow-up data from the Swiss IBD cohort study
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Frei1, N. Fournier2, J. Zeitz3, M. Scharl1, B. Morell1, T. Greuter1, P. Schreiner1, B. Misselwitz1, E. Safroneeva4, A. Schoepfer5, S.R. Vavricka6, G. Rogler1, L. Biedermann on behalf of the Swiss IBD Cohort Study Group7*

Created: Thursday, 21 February 2019, 9:14 AM
P513: Managing IBD patients on adalimumab based on trough levels and antibodies
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Parisi I., Atherton R., McCartney S., Vega R., Mehta S., Whitley L., Kabir M., Kiparissi F., Bloom S.

Created: Wednesday, 20 February 2019, 10:36 AM
P513: Performance of a rapid test for adalimumab monitoring vs. conventional ELISA in a routine laboratory setting
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Van Stappen*1, B. H. Roovers2, F. van Deurzen2, A. J. van Vuuren2

Created: Friday, 22 February 2019, 9:41 AM
P513: Prospective study on patients' satisfaction and impact on quality of life of corticosteroid therapy in patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Navarro Llavat, M.(1)*;García-Bosch, O.(1);Castro-Poceiro, J.(1);Bargalló García, A.(1);Ruiz Arroyo , D.(1);Navas Bravo , Y.(1);Erice Muñoz, E.(1);Barquero Declara, D.(1);Mata Bilbao, A.(1);Martín Llahí , M.(1);Ariza Solé, X.(1);Hernández Ballesteros, C.(1);Juan Juan , A.(1);Bustamante Robles, K.(1);Berbel Comas, C.(1);Blasco Pelicano, A.(1);Albareda Riera, M.(2);Domènech Morral , E.(3);
Created: Friday, 14 July 2023, 11:05 AM
P513: Treatment persistence in bio-naive patients with long-standing Crohn's disease treated with first-line biologics: real-life data from a Croatian tertiary center.
Year: 2022
Source: ECCO'22
Authors: Biscanin, A.(1);Tomasic, V.(1);Babic, F.(2);Dorosulic, Z.(1);Kralj, D.(1);Cacic, P.(1);Ogresta, D.(1);Hrabar, D.(1);
Created: Friday, 11 February 2022, 3:56 PM
P514 Does faecal diversion induce clinical response for Crohn’s disease of the colorectum?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Lightner1, H. Buhulaigah2, K. Zaghiyan2, P. Vaidya1, M. Regueiro1, P. Fleshner2

Created: Thursday, 30 January 2020, 10:12 AM
P514: Combination treatment with vedolizumab and anti-TNF-α in inflammatory bowel disease: safety data
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Buer L.*1,2, Høivik M.L.1, Medhus A.W.1, Moum B.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P514: Factors affecting clinical and endoscopic outcomes of placebo arm in trials of biologics and small-molecule drugs in ulcerative colitis: A meta-analysis
Year: 2018
Source: ECCO '18 Vienna
Authors:

F.S. Macaluso1*, M. Maida2, S. Renna1, M. Ventimiglia1, M. Cottone1, A. Orlando1

Created: Thursday, 21 February 2019, 9:14 AM